SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-043844
Filing Date
2023-04-11
Accepted
2023-04-11 08:30:44
Documents
12
Period of Report
2023-04-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2312238d1_8k.htm   iXBRL 8-K 25996
  Complete submission text file 0001104659-23-043844.txt   199816

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA irwd-20230410.xsd EX-101.SCH 3051
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE irwd-20230410_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE irwd-20230410_pre.xml EX-101.PRE 22607
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2312238d1_8k_htm.xml XML 3608
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34620 | Film No.: 23812431
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences